Mon07282014

Last update 09:05:27 AM EST

NASP and SPAARx Merge to Create a  Unified Specialty Pharmacy Association

NASP and SPAARx Merge to Create a Unified Specialty Pharmacy Association

NASP/SPAARx merger creates one, unified voice re...

Nexavar Fails in Late-Stage Breast Cancer Trial

Nexavar Fails in Late-Stage Breast Cancer Trial

Today, Bayer and Amgen’s Onyx Pharmaceuticals ...

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

Gilead Sciences, Inc. announced that the US Fo...

FDA Approves Strides' Transplant Drug

FDA Approves Strides' Transplant Drug

Today, Strides Arcolab announced that the US F...

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca recently announced that its biolog...

HIV Diagnosis Rate Down More than 30 Percent in the US

HIV Diagnosis Rate Down More than 30 Percent in the US

Researchers recently reported that the annual rate for diagnosis for HIV infec...

Alphaeon to Acquire Specialty Nutriceutical Company PRN

Alphaeon to Acquire Specialty Nutriceutical Company PRN

Today, Alphaeon Corporation announced that it has acquired Physician Recomme...

AstraZeneca Signs Deals for Cancer Diagnostic Tests with Roche and Qiagen

AstraZeneca Signs Deals for Cancer Diagnostic Tests with Roche and Qiagen

Today, AstraZeneca announced that it has entered into deals with both Roche ...

Bristol-Myers Squibb Enters Cancer Immunotherapy Deal with Ono Pharmaceutical

Bristol-Myers Squibb Enters Cancer Immunotherapy Deal with Ono Pharmaceutical

Bristol-Myers Squibb (BMS) and Ono Pharmaceutical recently announced that th...

Onco360 Included in Zydelig's Limited Distribution Network

Onco360 Included in Zydelig's Limited Distribution Network

Onco360 recently announced that it has been selected to be part of the limit...

NASP and SPAARx Merge to Create a Unified Specialty Pharmacy Association

NASP and SPAARx Merge to Create a  Unified Specialty Pharmacy Association

NASP/SPAARx merger creates one, unified voice representing the fastest growing...

Breakthrough Blood Test Shows Promising Results in Detecting Cancer

Breakthrough Blood Test Shows Promising Results in Detecting Cancer

A team of researchers from the University of Bradford have developed a simple ...

FDA Accepts Sandoz's Application for Biosimilar Filgrastim

FDA Accepts Sandoz's Application for Biosimilar Filgrastim

The US Food and Drug Administration (FDA) has accepted an application by San...

Nexavar Fails in Late-Stage Breast Cancer Trial

Nexavar Fails in Late-Stage Breast Cancer Trial

Today, Bayer and Amgen’s Onyx Pharmaceuticals subsidiary announced that thei...

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

Gilead Sciences, Inc. announced that the US Food and Drug Administration (FD...

Puma Shares Triple on Positive Late-Stage Results of its Breast Cancer Drug

Puma Shares Triple on Positive Late-Stage Results of its Breast Cancer Drug

On Tuesday, Puma Biotechnology, Inc. announced that its experimental breast ...

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca recently announced that its biologics research and development a...

FDA Grants Priority Review for Genentech's Avastin in Platinum-Resistant Ovarian Cancer

FDA Grants Priority Review for Genentech's Avastin in Platinum-Resistant Ovarian Cancer

On Tuesday, Genentech, a member of the Roche Group, announced that its suppl...

Researchers Identify Potential Target for Immunotherapy in Patients with Early-Stage Breast Cancer

Researchers Identify Potential Target for Immunotherapy in Patients with Early-Stage Breast Cancer

Researchers from the Yale Cancer Center utilized a novel molecular analysis to...

FDA Approves Strides' Transplant Drug

FDA Approves Strides' Transplant Drug

Today, Strides Arcolab announced that the US Food and Drug Administration (F...